JP2011178784A5 - - Google Patents

Download PDF

Info

Publication number
JP2011178784A5
JP2011178784A5 JP2011034961A JP2011034961A JP2011178784A5 JP 2011178784 A5 JP2011178784 A5 JP 2011178784A5 JP 2011034961 A JP2011034961 A JP 2011034961A JP 2011034961 A JP2011034961 A JP 2011034961A JP 2011178784 A5 JP2011178784 A5 JP 2011178784A5
Authority
JP
Japan
Prior art keywords
water
results
shows
particles
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011034961A
Other languages
English (en)
Japanese (ja)
Other versions
JP5616251B2 (ja
JP2011178784A (ja
Filing date
Publication date
Priority claimed from GB0305322A external-priority patent/GB0305322D0/en
Application filed filed Critical
Publication of JP2011178784A publication Critical patent/JP2011178784A/ja
Publication of JP2011178784A5 publication Critical patent/JP2011178784A5/ja
Application granted granted Critical
Publication of JP5616251B2 publication Critical patent/JP5616251B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011034961A 2003-02-12 2011-02-21 固形腫瘍の化学的塞栓療法用組成物 Expired - Lifetime JP5616251B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03250868 2003-02-12
EP03250868.1 2003-02-12
GB0305322.0 2003-03-07
GB0305322A GB0305322D0 (en) 2003-03-07 2003-03-07 Chemoembolisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006500252A Division JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物

Publications (3)

Publication Number Publication Date
JP2011178784A JP2011178784A (ja) 2011-09-15
JP2011178784A5 true JP2011178784A5 (enExample) 2012-05-17
JP5616251B2 JP5616251B2 (ja) 2014-10-29

Family

ID=32870779

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006500252A Expired - Lifetime JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物
JP2011034961A Expired - Lifetime JP5616251B2 (ja) 2003-02-12 2011-02-21 固形腫瘍の化学的塞栓療法用組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006500252A Expired - Lifetime JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物

Country Status (9)

Country Link
EP (1) EP1592405B1 (enExample)
JP (2) JP4895802B2 (enExample)
KR (1) KR101157260B1 (enExample)
CN (4) CN102895662B (enExample)
AT (1) ATE396708T1 (enExample)
DE (1) DE602004014101D1 (enExample)
ES (1) ES2308149T3 (enExample)
HK (1) HK1079980B (enExample)
WO (1) WO2004071495A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE01918975T1 (de) 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
WO2005087193A2 (en) * 2004-03-11 2005-09-22 Biocompatibles Uk Limited Chemoembolisation involving an anthracycline compound
EP3085361A1 (en) * 2004-09-07 2016-10-26 Biocompatibles UK Limited Compositions comprising camptothecins in microspheres
KR20140090270A (ko) * 2005-05-09 2014-07-16 바이오스피어 메디칼 에스.에이. 마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
US20080305176A1 (en) * 2006-01-24 2008-12-11 Biocompatibles Uk Limited Process For Loading Polymer Particles With Drug
WO2007090127A2 (en) 2006-01-30 2007-08-09 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
EP2034951B2 (en) 2006-06-22 2020-03-25 Biocompatibles UK Limited Rehydratable pharmaceutical product
EP1985286A1 (en) 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
JP5302300B2 (ja) * 2007-05-11 2013-10-02 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ アンスラサイクリンの医薬組成物
WO2009022190A1 (en) * 2007-08-16 2009-02-19 Biocompatibles Uk Limited Delivery of drug combinations
EP3181123A1 (en) 2008-12-02 2017-06-21 Biocompatibles Uk Ltd. Pancreatic tumour treatment
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
US20150224221A1 (en) 2012-08-31 2015-08-13 Chung-Ang University Industry-Academic Cooperation Foundation Method for preparing microspheres for emboli, and method for preparing microspheres to which drug-containing carrier is bound
JP6420817B2 (ja) * 2013-03-15 2018-11-07 バイオコンパティブルズ ユーケー リミテッド 結像可能な塞栓性微小球
GB2519738A (en) 2013-09-06 2015-05-06 Biocompatibles Uk Ltd Radiopaque polymers
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
PL3264997T3 (pl) 2015-03-02 2019-07-31 Accurate Medical Therapeutics Ltd. Cewniki z otworami bocznymi do modyfikowania i podawania zawiesin pacjentowi
GB201515602D0 (en) 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
CN115137870B (zh) 2016-03-14 2024-05-10 生物相容性英国公司 包含颗粒的乳液
JP6921116B2 (ja) 2016-05-04 2021-08-18 アキュレイト メディカル セラピューティクス リミテッド スリットパターンを有する塞栓マイクロカテーテルヘッド
US11382990B2 (en) 2016-11-16 2022-07-12 The Usa, As Represented By The Secretary, Dhhs Imageable polymers, methods of making and methods of use thereof
CN116173284B (zh) * 2017-07-13 2025-09-19 瓦里安医疗系统公司 栓塞微球
JP7364193B2 (ja) 2017-11-02 2023-10-18 アキュレイト メディカル セラピューティクス リミテッド 内蔵フィルタを有する塞栓術用カテーテル
TW202000189A (zh) 2018-06-29 2020-01-01 英商白康帝英國有限公司 不透射線聚合物
CN113727699A (zh) 2019-03-22 2021-11-30 生物相容英国有限公司 栓塞微球和方法
WO2020234889A1 (en) 2019-05-23 2020-11-26 Accurate Medical Therapeutics Ltd. Embolization catheter for reflux free delivery of microspheres
GB201910286D0 (en) 2019-07-18 2019-09-04 Biocompatibles Uk Ltd Radiopaque polymers
AU2021227230A1 (en) * 2020-02-25 2022-09-08 Hepion Pharmaceuticals, Inc. Use of cyclosporine analogues for treating cancer
CN114099442B (zh) * 2020-08-25 2024-01-30 复旦大学 用于肿瘤放化疗栓塞治疗和影像的多功能微球制剂及其制备方法
CN113797383A (zh) * 2021-09-28 2021-12-17 迪格瑞医疗科技(苏州)有限公司 一种高弹性、高载药量的栓塞微球及其制备方法
CN118434411A (zh) 2021-12-23 2024-08-02 波士顿科学医疗设备有限公司 化学栓塞组合物及其治疗方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978713A (en) * 1987-12-16 1990-12-18 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
JP3041627B2 (ja) * 1989-04-13 2000-05-15 武田薬品工業株式会社 アントラサイクリン系抗生物質の安定組成物
JPH06329542A (ja) * 1993-05-21 1994-11-29 Kibun Food Chemifa Co Ltd 不溶性アルギン酸塩粒子を含む局所血管止血用組成物および動脈化学塞栓用組成物
DE69432867T2 (de) * 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood Zubereitung mit gesteuerter freisetzung
WO1999012577A1 (en) * 1997-09-05 1999-03-18 Nycomed Imaging As Polymer particles made of polyvinyl alcohol and comprising a contrast agent for chemoembolization
EP1263803B1 (en) * 2000-03-13 2007-09-19 BioCure, Inc. Embolic compositions
AU2001292092A1 (en) * 2000-10-06 2002-04-15 Biocompatibles Uk Limited Zwitterionic polymers
US20060165804A1 (en) * 2002-09-25 2006-07-27 Lewis Andrew L Polymer compositions for administration to animals

Similar Documents

Publication Publication Date Title
JP2011178784A5 (enExample)
JP2011525477A5 (enExample)
JP2015205922A5 (enExample)
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
ES2688889T3 (es) Proceso de mezcla sin disolvente para el recubrimiento de ingredientes farmacéuticos
RU2015128609A (ru) Перенасыщенные стабилизированные наночастицы для слаборастворимых лекарственных средств
RU2011102777A (ru) Частицы с покрытием, содержащие фармацевтически активные агенты
JP2010090168A5 (enExample)
JP2015511953A5 (enExample)
JP2014005302A5 (enExample)
JP2011529039A5 (enExample)
MX2008014456A (es) Procedimiento para preparar microesferas para liberacion sostenida que tienen capacidad mejorada de dispersion y capacidad de inyeccion.
JP2008280351A5 (enExample)
JP2015533164A5 (enExample)
JP2010537989A5 (enExample)
JP2014528431A5 (enExample)
NZ609840A (en) Process for making multiparticulate gastroretentive dosage forms
WO2009034541A3 (en) Controlled release pharmaceutical dosage forms of trimetazidine
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
JP2017536401A5 (enExample)
JP2014516080A5 (enExample)
JP2017537168A5 (enExample)
IL255113B (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2006097558A3 (es) Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas
WO2010017215A3 (en) Biodegradable microspheres and methods of use thereof